组织肺炎与扩散膜出血诱导的坎波医学choreitoito
Seijitsu Ando1, Koji Azuma1, Shinji Futami1
1Department of Respiratory Medicine, NHO Osaka National Hospital, Osaka, Japan.
坎波药物可能会导致严重的肺损伤,包括组织肺炎与扩散膜出血. 停止使用草药治疗,使得患者的肺部损伤在没有使用类固醇的情况下得到解决.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 传统日本医学是传统的日本医学.
背景情况:
- 坎波医药是一种传统的日本草药疗法,被广泛使用,并受到国家医疗保险的保障.
- 虽然通常是安全的,但Kampo配方存在严重副作用的风险,特别是肺部损伤.
更多相关视频
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
相关概念视频
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
